References

Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2024 · External reference

Risk Factors and Prediction Models for Cardiotoxicity Induced by Anthracyclines in Malignant Chemotherapy

10.1007/s00280-025-04795-4 · 2025 · External reference

Pathophysiology of Doxorubicin‐Mediated Cardiotoxicity

10.3390/toxics13040277 · 2025 · External reference

2022 ESC Guidelines on Cardio‐Oncology Developed in Collaboration With the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio‐Oncology Society (IC‐OS)

10.1093/eurheartj/ehac244 · 2022 · External reference

Prognostic Impact of Global Longitudinal Strain and NT‐proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated With Anthracycline‐Based Chemotherapy

10.3390/medicina59050953 · 2023 · External reference

Predictive Value of Baseline Left Ventricular Global Longitudinal Strain for Cardiac Dysfunction in Patients With Moderate to High Risk of Cancer Therapy‐Related Cardiovascular Toxicity

10.3390/ph18101530 · 2025 · External reference

Left Atrial Reservoir Longitudinal Strain and Its Incremental Value to the Left Ventricular Global Longitudinal Strain in Predicting Anthracycline‐Induced Cardiotoxicity

10.1111/echo.15805 · 2024 · External reference

Strain‐Guided Management of Potentially Cardiotoxic Cancer Therapy

10.1016/j.jacc.2020.11.020 · 2021 · External reference

Machine Learning for Cardio‐Oncology: Predicting Global Longitudinal Strain From Conventional Echocardiographic Measurements in Cancer Patients

2025 · External reference

Nomogram for Predicting Risk of Cancer Therapy‐Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2‐Positive Breast Cancer

10.1161/jaha.123.029465 · 2023 · External reference

Development and Validation of a Predictive Model for Cancer Therapy‐Related Cardiac Dysfunction in Breast Cancer Patients Using Echocardiographic Indicators

10.62347/wpuw2205 · 2025 · External reference

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement

10.1136/bmj.g7594 · 2015 · External reference

Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging

10.1016/j.echo.2014.11.003 · 2015 · External reference

Cancer Therapy‐Related Cardiac Dysfunction: A Review of Current Trends in Epidemiology, Diagnosis, and Treatment

10.3390/biomedicines12122914 · 2024 · External reference

Artificial Intelligence‐Enabled Prediction of Chemotherapy‐Induced Cardiotoxicity From Baseline Electrocardiograms

10.1038/s41467-024-45733-x · 2024 · External reference

Machine Learning Models Using Multimodal Data Accurately Predict Chemotherapy‐Induced Cardiotoxicity in Breast Cancer

10.3389/fcvm.2025.1707889 · 2025 · External reference

Global Longitudinal Strain: An Early Marker for Cardiotoxicity in Patients Treated for Breast Cancer

10.1007/s12471-022-01734-3 · 2023 · External reference

Global Longitudinal Strain in Cardio‐Oncology: A Review

10.3390/cancers15030986 · 2023 · External reference

Chemotherapy‐Induced Cardiotoxicity: Mechanisms, Detection and Emerging Therapies in Cardio‐Oncology

10.15190/d.2025.16 · 2025 · External reference

Risk Factors From Framingham Risk Score for Anthracyclines Cardiotoxicity in Breast Cancer: A Systematic Review and Meta‐Analysis

10.3389/fcvm.2023.1101585 · 2023 · External reference

Lipid Metabolism and Breast Cancer: A Narrative Review of the Prognostic Implications and Chemotherapy‐Induced Dyslipidemia

2025 · External reference

Anthracycline Cardiotoxicity in Adult Cancer Patients: JACC: CardioOncology State‐of‐the‐Art Review

10.1016/j.jaccao.2024.07.016 · 2024 · External reference

ALOX15 Modulates Ferroptosis via the Reactive Oxygen Species‐Mediated MAPK Pathway in Doxorubicin‐Induced Cardiotoxicity

10.1089/ars.2023.0468 · 2025 · External reference

Doxorubicin‐Induced Cardiotoxicity: A Comprehensive Update

10.3390/jcdd12060207 · 2025 · External reference

Is Dyslipidemia a Risk Factor for Trastuzumab‐induced Cardiotoxicity in Breast Cancer Patients? A Systematic Review and Meta‐Analysis

10.1016/j.repc.2022.10.016 · 2023 · External reference

Analysis of Cardiotoxicity and Risk Factors of Breast Cancer Chemotherapy Drugs: A Five‐Year Single‐Centre Retrospective Study in Early Breast Cancer

10.2147/dddt.s516457 · 2025 · External reference

Safety of Continuing Trastuzumab for Mild Cardiotoxicity: A Cardiovascular Magnetic Resonance Imaging Study

10.1016/j.cjco.2024.03.007 · 2024 · External reference

Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab

10.1007/s12012-024-09861-6 · 2024 · External reference

Left Atrial Strain as a Predictor of Early Anthracycline‐Induced Chemotherapy‐Related Cardiac Dysfunction: A Pilot Systematic Review and Meta‐Analysis

10.3390/jcm13133904 · 2024 · External reference

Atrial Strain Assessment for the Early Detection of Cancer Therapy‐Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio‐Oncology)

10.3390/jcm12227127 · 2023 · External reference

Evaluating Cardiovascular Risk Factors in Breast Cancer Survivors: The Role of Echocardiography and Cardiopulmonary Exercise Testing in the Munich Cardio‐Oncology‐Exercise Retrospective Registry

10.1016/j.ijcard.2025.133421 · 2025 · External reference